Johnson & Johnson Total Liabilities 2010-2024 | JNJ

Johnson & Johnson total liabilities for the quarter ending June 30, 2024 were $109.550B, a 4.97% decline year-over-year.

  • Johnson & Johnson total liabilities for 2023 were $98.784B, a 10.66% decline from 2022.
  • Johnson & Johnson total liabilities for 2022 were $110.574B, a 2.39% increase from 2021.
  • Johnson & Johnson total liabilities for 2021 were $107.995B, a 3.24% decline from 2020.

Johnson & Johnson Total Liabilities 2010-2024 | JNJ

  • Johnson & Johnson total liabilities for 2023 were $98.784B, a 10.66% decline from 2022.
  • Johnson & Johnson total liabilities for 2022 were $110.574B, a 2.39% increase from 2021.
  • Johnson & Johnson total liabilities for 2021 were $107.995B, a 3.24% decline from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$861.3B
Novo Nordisk (NVO)$592.4B
AbbVie (ABBV)$341.7B
Merck (MRK)$299.6B
AstraZeneca (AZN)$243.5B
Novartis AG (NVS)$236.5B
Pfizer (PFE)$169B
Sanofi (SNY)$144.1B
Innoviva (INVA)$1.2B